Paper Review Records
All Paper Review Records
18 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
70
days
Late acquisition of BCR::ABL1 during clonal evolution of SAMD9- associated MDS with phenotypic shift from AML to B-ALL
Authors
Yusuke Nakata; Anna Hiratsuka; Takeshi Yoroidaka; Wakana Takahashi; Itaru Nishikawa; Masataka Sakashita; Shinya Yamada; Hiroki Mizumaki; Akiyo Yoshida; Tatsuya Imi; Hiroyuki Maruyama; Hiroyuki Takamatsu; Kohei Hosokawa; Yasuhito Nannya; Seishi Ogawa; Toshihiro MiyamotoShow moreShow less
Affiliations
1. Department of Hematology, Faculty of Medicine, Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan; 2. Division of Hematology, Keiju Kanazawa Hospital, Kanazawa, Japan; 3. Division of Hematopoietic Disease Control, Institute of Medical Science, The University of Tokyo, Tokyo, Japan; 4. Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, JapanShow moreShow less
119
days
Improved post-transplant outcomes following inotuzumab ozogamicin-based salvage therapy in relapsed/refractory B-ALL: a real-world retrospective study
Authors
Ryo Koizumi; Shinsuke Takagi; Aya Nishida; Mika Kuno; Rikako Tabata; Otoya Watanabe; Kyosuke Yamaguchi; Kosei Kageyama; Daisuke Kaji; Yuki Taya; Kazuya Ishiwata; Hisashi Yamamoto; Akiko Masuda; Yukako Koike; Hideki Araoka; Yuki Asano-Mori; Go Yamamoto; Atsushi Wake; Shuichi Taniguchi; Naoyuki UchidaShow moreShow less
Affiliations
1. Department of Hematology, Toranomon Hospital, Tokyo, Japan; 2. Center for Long-Term Follow-Up After Hematopoietic Cell Transplantation, Toranomon Hospital, Tokyo, Japan; 3. Okinaka Memorial Institute for Medical Research, Tokyo, Japan; 4. Department of Hematology, Toranomon Hospital Kajigaya, Kawasaki, Japan; 5. Department of Transfusion and Cellular Therapy, Toranomon Hospital, Tokyo, Japan; 6. Center for Cellular Therapy, Toranomon Hospital, Tokyo, Japan; 7. Department of Clinical Laboratory, Toranomon Hospital, Tokyo, JapanShow moreShow less
113
days
Gene editing of hematopoietic stem cells: applications and advances
Authors
Qiuyang Li; Hongxia Wang; Yuqin He; Genyue Hong; Guoxiu BaoShow moreShow less
Affiliations
1. Department of Hematology, Dali Bai Autonomous Prefecture People’s Hospital in Dali, Dali City, ChinaShow moreShow less
68
days
Long-term treatment-free remission in CML after early dasatinib discontinuation due to interstitial pneumonitis
Authors
Makoto Kashimura; Yuki Fujioka; Yong-Mei Guo; Teruko Takahashi; Keiichi Moriya; Naoto TakahashiShow moreShow less
Affiliations
1. Division of Hematology, Shinmatsudo Central General Hospital, Matsudo, Japan; 2. Division of Central Laboratory, Akita University Hospital, Akita, Japan; 3. Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, Akita, JapanShow moreShow less
205
days
Efficacy and safety of maribavir in Japanese patients with post-transplant cytomegalovirus infections: a phase III study
Authors
Yoshinobu Kanda; Katsuto Takenaka; Tatsu Tanabe; Kazuya Omoto; Kei Kamimura; Kentaro Kudou; Masato KanekoShow moreShow less
Affiliations
1. Division of Hematology, Jichi Medical University, Shimotsuke, Japan; 2. Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University, Matsuyama, Japan; 3. Department of Kidney Transplant Surgery, Sapporo City General Hospital, Sapporo, Japan; 4. Yochomachi Clinic, Tokyo, Japan; 5. Takeda Pharmaceutical Company Limited, Osaka, JapanShow moreShow less
71
days
TFH phenotype and response to tucidinostat in relapsed/refractory PTCL: analysis of patients from a phase IIb trial
Authors
Koji Izutsu; Ayumi Fujimoto; Shinya Rai; Dai Maruyama; Ken Ohmachi; Akihiko Yokohama; Kunihiro Tsukasaki; Toshiki Uchida; Junya Kuroda; Ilseung Choi; Michihiro Hidaka; Jun Ando; Takashi Sakamoto; Hisashi Kato; Hironobu Minami; Shinichiro Yoshida; Matsuo Yamamoto; Mireille Gillings; Hiroshi Onogi; Kengo TakeuchiShow moreShow less
Affiliations
1. Department of Hematology, National Cancer Center Hospital, Tokyo, Japan; 2. Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan; 3. Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan; 4. Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Sakai, Japan; 5. Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan; 6. Department of Hematology and Oncology, Tokai University Hospital, Isehara, Japan; 7. Department of Hematology, Gunma University Hospital, Maebashi, Japan; 8. Department of Hematology, International Medical Center, Saitama Medical University, Hidaka, Japan; 9. Department of Hematology and Oncology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan; 10. Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan; 11. Department of Hematology and Cell Therapy, NHO Kyushu Cancer Center, Fukuoka, Japan; 12. Department of Hematology, NHO Kumamoto Medical Center, Kumamoto, Japan; 13. Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan; 14. Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; 15. Department of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Suita, Japan; 16. Division of Medical Oncology and Hematology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan; 17. Department of Hematology, NHO Nagasaki Medical Center, Omura, Japan; 18. Clinical Research Center, NHO Nagoya Medical Center, Nagoya, Japan; 19. HUYA BIO International, LLC, San Diego, USA; 20. Huya Japan GK, Tokyo, JapanShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
